US Earnings Financial Results SEC Filings — June 15, 2026

15-06-2026

Alternus Clean Energy, Inc. (ALCE) filed its 10-K annual report, highlighting a capital-light, Energy-as-a-Service (EaaS) model with over 70% of EverOn's near-term growth already in a blue-chip pipeline, providing clear revenue visibility. However, the company faces material risks including substantial indebtedness that could reduce cash flow available for operations and growth, potential negative impacts from U.S. tariffs on critical minerals used in solar manufacturing, and the risk that reductions in clean energy incentives could diminish market demand and financing availability.

• · The company's capital-light model delivers energy under long-term service contracts, removing upfront capital expenditure for customers while retaining ownership of income-generating assets.
• · A delay between making significant upfront investments in renewable energy projects and receiving revenue could materially and adversely affect liquidity, business, and results of operations.
• · Substantial indebtedness requires dedicating a substantial portion of cash flow to debt repayment, reducing availability for working capital, capital expenditures, acquisitions, or joint ventures.
• · Potential U.S. tariffs on processed critical minerals (including tellurium) under Section 232 could negatively impact demand, price levels, net sales, or increase costs for solar modules.
• · Limitations on tax incentives (Section 45X, ITC, PTC) could reduce economic returns for manufacturers and investors, reducing financing availability and demand for solar and wind components.

15-06-2026

Coda Octopus Group reported strong financial results for the six months ended April 30, 2026, with net income increasing 44.3% YoY to $2.63M and revenue growing 11.3% to $13.61M. However, Q3 revenue declined slightly by 1.6% YoY to $6.90M, and the company recorded a significant foreign currency translation loss of $441,547 in Q3, contributing to a mixed quarterly comprehensive income result.

• · Gross profit margin improved to 65.7% for the six months ended April 30, 2026, compared to 64.8% in the prior year period.
• · Selling, general & administrative expenses decreased 10.5% YoY in Q3 to $2.14M, but remained relatively flat on a six-month basis at $4.89M.
• · Research & development expenses were relatively stable, decreasing 6.0% YoY in Q3 to $648,304.
• · The company recorded a foreign currency translation loss of $441,547 in Q3 2026, compared to a gain of $1.80M in Q3 2025.
• · Accumulated deficit improved significantly from ($3.28M) at October 31, 2025 to ($0.65M) at April 30, 2026.
• · Total liabilities decreased 7.1% from $6.38M to $5.92M over the same period.
• · The company repurchased $13,669 of treasury stock during the six-month period.
• · Deferred revenue increased 11.9% to $1.97M (current portion) as of April 30, 2026.

15-06-2026

SafeSpace Global Corp (SSGC) reported its first-ever revenue of $11,258 for the three and nine months ended April 30, 2026, compared to zero revenue in the prior-year periods. However, the company's net loss widened significantly to $3,468,006 for the quarter (vs. $1,310,643) and $6,209,993 for the nine months (vs. $3,261,217), driven by a $1,222,580 impairment of intangibles and a sharp increase in SG&A expenses. Cash and cash equivalents fell 77% from $7,546,390 to $1,738,472, and the accumulated deficit grew to $27,163,216, reflecting ongoing cash burn and operating losses.

• · Gross margin was negative $(28,013) for both the three and nine months ended April 30, 2026, as cost of revenue of $39,271 exceeded revenue.
• · Operating loss for the three months ended April 30, 2026 was $3,491,412, compared to $1,424,783 in the prior-year period, an increase of 145%.
• · Operating loss for the nine months ended April 30, 2026 was $6,342,529, compared to $3,343,720 in the prior-year period, an increase of 89.7%.
• · Interest income for the nine months ended April 30, 2026 was $132,536, up from $7,367 in the prior-year period.
• · The company had no proceeds from issuance of common stock in the nine months ended April 30, 2026, compared to $10,172,074 in the prior-year period.
• · Net cash used in operating activities for the nine months ended April 30, 2026 was $4,607,003, up from $1,754,005 in the prior-year period.
• · The company invested $1,200,915 in investing activities (development of intangibles and capital expenditures) in the nine months ended April 30, 2026, compared to zero in the prior-year period.
• · Total assets decreased from $7,930,903 (July 31, 2025) to $3,006,842 (April 30, 2026), a decline of 62.1%.
• · Total liabilities increased from $366,011 (July 31, 2025) to $1,045,233 (April 30, 2026), an increase of 185.6%, primarily due to new operating lease liabilities of $686,321.
• · The company recorded a right-of-use asset of $643,811 and a tenant improvement allowance receivable of $5,705 as of April 30, 2026, with no such assets in the prior period.
• · Net loss per share (basic and diluted) was $(0.02) for the three months ended April 30, 2026, compared to $(0.01) in the prior-year period.
• · Net loss per share (basic and diluted) was $(0.03) for the nine months ended April 30, 2026, unchanged from the prior-year period.

15-06-2026

Adobe reported Q2 FY2026 revenue of $6.618B, up 12.7% YoY, and net income of $1.712B, up 1.2% YoY. Subscription revenue grew 13.7% to $6.416B, while services and other revenue declined 21.5% to $113M. Operating income rose 6.1% to $2.238B, but gross margin slightly compressed from 89.1% to 89.2%. The company repurchased $2.13B in stock during the quarter and completed an acquisition that added $1.184B to goodwill.

• · Goodwill increased by $1.184B from $12.857B to $14.041B, reflecting an acquisition during the period.
• · Total debt (current + long-term) stood at $6.645B as of May 29, 2026, compared to $6.210B at November 28, 2025.
• · Cash and cash equivalents decreased by $512M to $4.919B from $5.431B at year-end.
• · Stock-based compensation for Q2 was $534M, up from $481M in the prior year quarter.
• · The effective tax rate for Q2 was 23.5% compared to 19.5% in Q2 FY2025.
• · Shares outstanding declined from 413M to 399M due to repurchases.
• · Deferred revenue (current) increased to $7.152B from $6.905B at year-end.

15-06-2026

VITASPRING BIOMEDICAL CO. LTD. reported no revenue for the three months ended April 30, 2025 and 2024, with a net loss of $80,541 in the current period compared to $216,831 in the prior year period. Total assets decreased to $11,912 from $14,378 as of January 31, 2025, while total liabilities increased to $4,107,653 from $4,029,578. The company's cash balance fell to $0 from $272, and stockholders' deficit widened to ($4,095,741) from ($4,015,200).

• · Selling, general and administrative expenses decreased to $69,147 from $216,831 in the prior year period.
• · Depreciation expense remained unchanged at $2,489 in both periods.
• · Stock-based compensation was $0 in the current period versus $41,217 in the prior year period.
• · Net cash used in operating activities improved to ($787) from ($4,023).
• · Advances from related party for operating expenses were $30,434 in the current period versus $270,613 in the prior year period.
• · Equipment and vehicle, net decreased to $11,617 from $14,106 due to depreciation.
• · Accounts payable and other payables increased to $530,498 from $494,751.
• · Income tax payable increased to $325,116 from $313,722.
• · Advances from related party (liability) increased to $841,039 from $810,105.
• · Accumulated deficit increased to ($5,362,044) from ($5,281,503).

15-06-2026

CH4 Natural Solutions Corp filed its 10-Q for the quarter ended March 31, 2026, reporting a net loss of $100,452, slightly higher than the $98,509 loss in the same quarter last year. The company has no revenue, minimal assets ($1.1M), and a shareholders' deficit of $372,191. Cash balance remains zero, and the company relies on related-party funding and deferred offering costs.

• · General and administrative expenses increased slightly from $98,509 in Q1 2025 to $100,452 in Q1 2026.
• · Deferred offering costs increased from $1,018,517 at Dec 31, 2025 to $1,073,606 at Mar 31, 2026.
• · Accounts payable increased from $0 at Dec 31, 2025 to $12,490 at Mar 31, 2026.
• · Accrued expenses increased from $512,925 at Dec 31, 2025 to $568,014 at Mar 31, 2026.
• · Due to related party increased from $509,158 at Dec 31, 2025 to $597,120 at Mar 31, 2026.
• · Weighted average shares outstanding remained constant at 6,666,667 for both periods.
• · Basic and diluted net loss per share was $(0.02) in Q1 2026 vs $(0.01) in Q1 2025.
• · Cash balance remained zero throughout both periods.
• · Noncash investing and financing activities: deferred offering costs included in accrued expenses were $55,089 in Q1 2026 vs $255,693 in Q1 2025.

15-06-2026

Greenwave Technology Solutions, Inc. (GWAV) filed its 10-K annual report for the year ended December 31, 2025, reporting a 40.1% increase in revenue to $46.66 million, driven by strong operational growth. However, gross profit declined 8.6% to $11.87 million, and the company reported a net loss available to common stockholders of $24.60 million, though this was a significant improvement from the $100.45 million loss in 2024. The company continues to face going concern risks and material weaknesses in internal controls.

• · Cash decreased 63.7% from $2.58 million to $0.94 million.
• · Total assets decreased 12.5% from $63.09 million to $55.17 million.
• · Total liabilities increased 11.9% from $26.13 million to $29.23 million.
• · Accumulated deficit grew to $520.91 million from $496.31 million.
• · Basic net loss per share improved from $(932.14) to $(41.25).
• · The company's independent registered public accounting firm expressed going concern doubts.
• · Material weaknesses in internal control over financial reporting were noted.
• · Revenue growth was driven by a 40.1% increase, but gross margin contracted significantly.

15-06-2026

Canopy Growth Corp reported net revenue of $284.6M for FY2026, up 6% YoY from $269.0M, driven by strong Canadian adult-use (+20%) and medical cannabis (+18%) growth. However, gross margin contracted to 24% from 30% due to higher cost of goods sold (+13%), and the Storz & Bickel segment declined 14% YoY. Net loss from continuing operations narrowed 49% to $262.9M, while total operating expenses rose 18% to $231.3M, largely from a 115% surge in asset impairment and restructuring costs.

• · Basic and diluted loss per share from continuing operations improved 82% to $(0.88) in FY2026 from $(4.79) in FY2025.
• · Total restructuring, asset impairments and related costs more than doubled to $77.0M in FY2026 from $33.2M in FY2025.
• · Goodwill impairment of $47.5M was the largest component of FY2026 asset impairment costs.
• · Share-based compensation swung from a credit of $4.2M in FY2025 to an expense of $4.3M in FY2026, a 201% change.
• · Other income (expense), net improved 74% to $(101.2M) from $(390.6M).
• · Income tax expense decreased 100% to $(23K) from $(7.1M).
• · Canadian adult-use cannabis revenue included excise taxes of $51.9M and other revenue adjustments of $3.9M in FY2026.
• · International markets cannabis revenue declined 7% YoY to $28.7M.
• · Storz & Bickel segment gross margin percentage fell 400 bps to 33%.
• · Cannabis segment gross margin percentage fell 400 bps to 22%.

15-06-2026

Dave & Buster's reported Q1 FY26 total revenues of $559.2M, down 1.5% YoY from $567.7M, driven by a 5.9% decline in entertainment revenues to $345.1M. Net income fell sharply to $5.7M from $21.7M, with diluted EPS dropping to $0.16 from $0.62. However, food and beverage revenues grew 6.5% to $214.1M, and operating cash flow improved to $113.8M from $95.8M.

• · Entertainment revenues declined 5.9% YoY to $345.1M, while food and beverage revenues increased 6.5% to $214.1M.
• · Operating income fell 25.8% to $46.9M from $63.2M.
• · Interest expense remained nearly flat at $36.9M vs $36.8M.
• · Capital expenditures decreased to $105.3M from $154.6M.
• · The company repurchased no shares in Q1 FY26 vs $23.9M in Q1 FY25.
• · Total debt decreased by $60.8M to $1,373.5M.
• · Deferred entertainment revenue decreased to $66.7M from $73.8M.
• · Accrued liabilities remained relatively flat at $301.1M vs $300.3M.

15-06-2026

DevvStream Corp. reported a net loss of $10.1M for the nine months ended April 30, 2026, compared to a $5.1M loss in the prior-year period, driven by a $3.6M inducement expense on loan conversion, a $2.4M loss on cryptocurrency revaluation, and a $1.2M default penalty on convertible debt. Revenue declined 12.8% to $8,863 from $10,164, and gross profit turned negative at ($1,314) versus $7,476 a year ago. However, the company raised $2.0M in PIPE financing, $1.7M from ELOC drawdowns, and $900,000 from a Series A preferred stock subscription, while significantly reducing total liabilities from $31.5M to $18.1M.

• · Total operating expenses decreased 29.6% to $6.6M for the nine months ended April 30, 2026, from $9.3M in the prior-year period, driven by reductions in professional fees and salaries.
• · The company recorded a $5.2M gain from the change in fair value of warrant liabilities, partially offsetting operating losses.
• · Cryptocurrencies – restricted of $2.7M were held as of April 30, 2026, compared to $0 at July 31, 2025.
• · Default penalty liability on convertible debt of $1.2M was recognized during the period.
• · The company issued 6,083,244 shares for settlement of debt during the nine months ended April 30, 2026.
• · Net cash used in operating activities increased 56.2% to $7.4M from $4.8M in the prior-year period.
• · The company had a working capital deficit of $16.9M as of April 30, 2026 (current liabilities of $18.1M vs current assets of $1.2M).
• · Accumulated deficit grew to $43.9M as of April 30, 2026, from $33.8M at July 31, 2025.
• · Weighted average basic shares outstanding increased to 5,866,870 for the nine months ended April 30, 2026, from 2,252,416 in the prior-year period.
• · Basic loss per share improved to ($1.73) from ($2.26) for the nine-month periods, despite the larger net loss, due to the higher share count.

15-06-2026

Zeo ScientifiX reported a significant improvement in net loss for the three months ended April 30, 2026, narrowing to $145,000 from $1,391,000 in the prior-year period, driven by a 125% revenue increase to $2,581,000 and a $390,000 gain on sale of Exotropin interests. However, the company remained unprofitable on an operating basis, with a loss from operations of $512,000, and cash used in operations increased to $609,000 from $78,000 in the prior-year period. For the six-month period, net loss improved to $997,000 from $2,634,000, while revenue grew 80% to $4,027,000.

• · Gross profit for the three months ended April 30, 2026 was $2,055,000, up from $893,000 in the prior-year period.
• · General and administrative expenses increased to $2,567,000 for the three months ended April 30, 2026 from $2,287,000 in the prior-year period.
• · The company raised $1,950,000 from the sale of common stock during the six months ended April 30, 2026.
• · Inventories increased to $686,000 at April 30, 2026 from $423,000 at October 31, 2025, driven by a rise in finished goods from $215,000 to $424,000.
• · Property and equipment, net increased to $609,000 at April 30, 2026 from $569,000 at October 31, 2025.
• · Equity in non-marketable securities was reduced to zero at April 30, 2026 from $145,000 at October 31, 2025, with a corresponding reserve reversal.
• · Accrued payroll related liabilities remained flat at $667,000 between periods.
• · Interest payable increased to $12,000 at April 30, 2026 from $1,000 at October 31, 2025.
• · Royalty payable decreased to $50,000 at April 30, 2026 from $100,000 at October 31, 2025.
• · Stock-based compensation for the six months ended April 30, 2026 was $1,182,000, down from $2,187,000 in the prior-year period.

15-06-2026

Forefront Tech Holdings Acquisition Corp filed its 10-Q for the quarter ended March 31, 2026, reporting total assets of $283,129 and total liabilities of $346,405, resulting in a shareholder's deficit of ($63,276). The company had no revenue and incurred a net loss of $31,905 for the three-month period, with general and administrative expenses of $31,905. The company remains a shell company with no cash on hand.

• · The company is a shell company with no cash on hand as of March 31, 2026.
• · Net cash used in operating activities was $0 for the three months ended March 31, 2026.
• · Noncash investing and financing activities included $98,046 in deferred offering costs included in accrued offering costs, $47,008 in deferred offering costs paid through promissory note - related party, and $38,349 in prepaid services contributed by Sponsor through promissory note - related party.
• · The company had 10,000,000 Class A ordinary shares outstanding as of June 12, 2026.
• · The company's securities are traded on NASDAQ under symbols FTHAU (Units), FTHA (Class A ordinary shares), and FTHAW (Warrants).
• · Warrants are exercisable for one Class A ordinary share at an exercise price of $11.50 per share.
• · Up to 500,000 Class B ordinary shares are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.
• · The company is an emerging growth company and a non-accelerated filer.

15-06-2026

Powerfleet, Inc. (AIOT) reported a significant improvement in financial performance for the fiscal year ended March 31, 2026, with total revenues growing 22.4% to $443.8M, driven by a 29.9% increase in services revenue to $359.8M. The company achieved a positive income from operations of $19.6M, a substantial turnaround from a loss of $25.9M in the prior year, and reduced its net loss attributable to common stockholders by 59.7% to $20.6M. However, product revenue declined 1.9% to $84.0M, and interest expense increased 35.4% to $27.5M, partially offsetting the operational gains.

• · The company's gross profit margin improved from 53.7% to 55.5% year-over-year.
• · Selling, general and administrative expenses as a percentage of revenue decreased from 56.4% to 47.0%.
• · Research and development expenses as a percentage of revenue decreased slightly from 4.4% to 4.1%.
• · The company reported a net loss before income taxes of $11.3M for FY 2026, compared to a loss of $46.5M in FY 2025.
• · Income tax expense increased from $4.5M to $8.7M year-over-year.
• · Depreciation and amortization increased from $47.5M to $60.3M.
• · Stock-based compensation decreased from $9.4M to $7.5M.
• · Restructuring-related expenses decreased from $10.1M to $4.9M.
• · Acquisition-related expenses decreased significantly from $21.3M to $1.7M.
• · Integration-related expenses decreased from $4.9M to $3.9M.
• · Goodwill increased from $383.1M to $412.0M.
• · Total liabilities increased from $463.3M to $474.0M.
• · Redeemable non-controlling interests were $6.0M as of March 31, 2026, compared to zero in the prior year.
• · Total Powerfleet, Inc. stockholders' equity increased from $446.6M to $475.5M.
• · The company had a foreign currency translation gain of $38.5M in FY 2026, compared to a loss of $7.9M in FY 2025.
• · Weighted-average common shares outstanding increased from 119.9M to 133.8M due to the private placement and MiX Combination.

15-06-2026

Domo, Inc. reported its Q1 FY27 results for the three months ended April 30, 2026. Total revenue declined 0.9% YoY to $79.4M, with subscription revenue falling 2.3% YoY to $69.8M, while professional services revenue grew 10.4% YoY to $9.6M. Net loss improved 21.5% YoY to $14.2M from $18.1M, and operating loss narrowed 23.6% to $11.0M. However, cash and cash equivalents decreased 9.1% to $39.1M, and the company's accumulated deficit widened to $1.56B.

• · Gross profit decreased 1.5% YoY to $58.5M from $59.4M.
• · Operating expenses declined 5.8% YoY to $69.5M, driven by reductions in sales & marketing (-5.2%), R&D (-6.6%), and G&A (-6.3%).
• · Stock-based compensation expense decreased 4.5% YoY to $14.8M.
• · Net cash provided by operating activities increased 30.9% to $5.2M from $4.0M.
• · Total debt (current + long-term) stood at $137.1M as of April 30, 2026, compared to $126.5M as of January 31, 2026, due to reclassification of long-term debt to current.
• · Deferred revenue (current) decreased 9.3% to $158.5M from $174.9M.
• · Warrant liability decreased 22.5% to $7.2M from $9.2M.
• · Accumulated deficit increased 0.9% to $1.56B from $1.55B.

15-06-2026

For the nine months ended April 30, 2026, revenue increased 15.3% year-over-year to $1.658M, while net loss narrowed by 9.4% to $(1.873M) compared to $(2.067M) in the prior-year period. However, gross margin declined to 57.7% from 58.1%, and the company's net loss for the three months ended April 30, 2026 widened to $(624K) from $(580K) a year ago. Total convertible debt outstanding rose to $5.77M, up from $4.80M at July 31, 2025.

• · PURE Hard Surface revenue for the three months ended April 30, 2026 declined 80.3% YoY to $92K from $468K, while SILVÉRION revenue surged to $414K from $21K, suggesting a major product mix shift.
• · For the nine-month period, PURE Hard Surface revenue grew 24.8% to $1.550M from $1.242M, but SILVÉRION revenue fell 45.1% to $106K from $193K.
• · Stock-based compensation increased 25.6% for the nine-month period to $147K, and 66.7% for the quarter to $55K.
• · Interest expense, net rose 43% for the nine-month period to $301K and 35.9% for the quarter to $106K, reflecting the higher debt load.
• · Other income nearly disappeared, dropping to $8K for the nine months from $79K, and to $0 for the quarter from $82K.
• · Raw materials inventory declined to $12K from $14K, but finished goods inventory jumped 73.2% to $220K.
• · Fiscal 2026 Notes ($970K total) were new debt issued during the period, maturing October 2028 to February 2029 with interest rates of 6.16%-6.68%.
• · Total shares issuable upon conversion of debt increased 46.4% to 57.76M from 39.45M.

15-06-2026

R F Industries reported a strong turnaround for the three and six months ended April 30, 2026, swinging to net income of $879K and $829K from net losses of $245K and $490K in the prior-year periods. Revenue grew 9.4% YoY to $20.7M in Q2 and 4.1% to $39.7M in the first half, driven by a new aerospace customer that accounted for 14% of Q2 sales. However, operating cash flow turned negative at -$47K in H1 2026 versus positive $2.8M a year ago, and cash reserves declined 33% to $3.4M.

• · Cost of sales increased to $13.4M in Q2 2026 from $13.0M in Q2 2025, but as a percentage of sales it improved to 64.9% from 68.5%.
• · Engineering expenses rose 34% YoY to $915K in Q2 2026, while selling and general expenses increased 1.8% to $5.3M.
• · Provision for income taxes decreased to $60K in Q2 2026 from $135K in Q2 2025.
• · Diluted EPS was $0.08 for Q2 2026 vs -$0.02 in Q2 2025.
• · Capital expenditures increased to $250K in H1 2026 from $61K in H1 2025.
• · Line of credit payments totaled $1.7M in H1 2026 vs $203K in H1 2025.
• · Income taxes paid surged to $876K in H1 2026 from $144K in H1 2025.
• · Aerospace customer represented 20% of accounts receivable at April 30, 2026, up from 10% a year earlier.
• · Wireless provider A and B each represented 11-16% of accounts receivable in prior periods but 0% in the current period.

15-06-2026

Crisp Momentum Inc. (CRSF) filed its 10-Q for the quarter ended April 30, 2026, reporting total revenues of $175 for the three-month period (up from $0 in the prior year) and $3,649 for the nine-month period (up from $126). However, the company posted a net loss of $4,563,146 for the quarter and $11,598,178 year-to-date, driven by a surge in general and administrative expenses to $4,805,384 (quarter) and $11,918,868 (nine months), including $8,837,101 in stock-based compensation. Cash decreased sharply from $305,120 to $100,538, while total assets rose to $1,336,045 largely due to new notes receivable.

• · Segment revenue for the nine months ended April 30, 2026: Services $2,982, Products/collectibles $667.
• · Segment profit (loss): Corporate Overhead ($11,918,868), Services $2,982, Collectibles $667.
• · Stock-based compensation of $8,837,101 was recognized in the nine months ended April 30, 2026 (none in prior period).
• · Impairment of intangibles of $390,508 was recorded in the nine months ended April 30, 2026.
• · Notes receivable increased from $0 to $1,235,507, and notes payable – related party increased from $31,000 to $751,939.
• · Treasury stock of 80,000,000 shares was acquired during the period, valued at $2,236,967.
• · Weighted average shares outstanding for the three months ended April 30, 2026: 2,049,621,210 (vs. 168,074,332 in prior year).
• · Cash used in investing activities was $4,490,508, primarily for notes receivable and related party receivables.
• · Cash provided by financing activities was $6,770,939, including $6,000,000 from related party common stock issuance and $720,939 from related party notes.
• · Non-cash investing/financing: Other receivable settled with return of treasury shares ($2,236,967) and assets acquired from settlement of note receivable ($750,000).

15-06-2026

15-06-2026

Pharma-Bio Serv reported a strong turnaround in Q2 2026, with net income of $232,986 compared to $95,353 in Q2 2025, driven by revenue growth of 11.8% to $2.7M and a significant reduction in SG&A expenses. However, cash and cash equivalents declined sharply to $1.79M from $3.38M at year-end, primarily due to a $1.72M dividend payment and negative operating cash flow, while retained earnings fell to $9.08M from $10.53M.

• · Gross profit for Q2 2026 was $902,041, up from $818,726 in Q2 2025, a 10.2% increase.
• · Income from operations swung to a profit of $144,676 in Q2 2026 from a loss of $(98,322) in Q2 2025.
• · Other income, net decreased to $94,677 in Q2 2026 from $199,186 in Q2 2025, a 52.5% decline.
• · Total current assets fell to $11.29M from $13.39M at year-end, a 15.7% decrease.
• · Total liabilities decreased to $1.05M from $1.74M at year-end, a 39.9% reduction.
• · Net cash used in operating activities was $(365,311) in Q2 2026 vs $(301,590) in Q2 2025, a 21.1% increase in cash burn.
• · The company paid $1.72M in dividends in Q2 2026, nearly equal to the $1.72M paid in Q2 2025.
• · Basic and diluted EPS for Q2 2026 was $0.010, up from $0.004 in Q2 2025.
• · Weighted average basic shares outstanding were 22,901,719 in Q2 2026 vs 22,934,385 in Q2 2025, a slight decline due to treasury stock purchases.
• · Accumulated other comprehensive income decreased to $254,960 from $278,045 at year-end, a 8.3% decline.

15-06-2026

Vistagen Therapeutics reported a significant increase in sublicense revenue to $1.269 million in FY2026 from $0.486 million in FY2025, representing a 161% YoY growth. However, the company's net loss widened to $69.685 million from $51.418 million, a 35.5% increase, driven by higher R&D expenses ($54.974 million vs. $39.375 million). Cash and cash equivalents decreased by 54.1% to $30.789 million, primarily due to increased operating cash outflows.

• · Stock-based compensation decreased 7.4% YoY to $3.997 million.
• · Net cash provided by financing activities surged 864.5% to $30.971 million, primarily from stock issuances under the Open Market Sale Agreement.
• · Weighted average shares outstanding increased 23.3% to 38,073,926.
• · Total assets declined 42.4% to $48.564 million due to cash burn.
• · Accumulated deficit reached $477.317 million, up from $407.632 million.

15-06-2026

Allied Gaming & Entertainment Inc. (AGAE) reported a net loss of $5.2M for Q1 2026, widening from a $4.9M loss in Q1 2025. Total revenues fell 31.7% YoY to $1.55M, driven by declines across all segments: in-person revenue dropped 36.5% to $1.05M and casual mobile gaming fell 19.0% to $500,779. However, operating expenses were reduced 32.6% YoY to $5.07M, partially offsetting the revenue decline. Cash and cash equivalents decreased sharply from $11.8M to $4.3M, while total assets fell 24.2% to $68.1M.

• · Multiplatform content revenue was negligible at $53 in Q1 2026, down from $57 in Q1 2025.
• · Loss on investment in marketable securities, derivatives and short-term investments was $1.63M in Q1 2026, compared to a loss of $275,276 in Q1 2025.
• · Loss on foreign currency transactions was $954,266 in Q1 2026, up from $565,296 in Q1 2025.
• · Interest income was $936,783 in Q1 2026, up from $864,305 in Q1 2025.
• · Net cash used in operating activities improved to $661,019 in Q1 2026 from $2.18M in Q1 2025.
• · Net cash provided by investing activities was $11.38M in Q1 2026, compared to $45.09M used in Q1 2025.
• · Net cash used in financing activities was $18.40M in Q1 2026, compared to $7.51M provided in Q1 2025.
• · Loans payable decreased from $33.14M at December 31, 2025 to $14.38M at March 31, 2026.
• · Accumulated deficit increased from $163.13M to $168.32M during Q1 2026.
• · Non-controlling interest was $2.98M as of March 31, 2026, up from $2.89M at December 31, 2025.

15-06-2026

Credo Technology Group reported a 205.7% YoY revenue surge to $1.335B for the fiscal year ended May 2, 2026, driven by strong demand across its product lines. Gross margin improved to 68.0% from 64.8% in the prior year, while net income margin expanded dramatically to 35.4% from 11.9%. However, operating expenses also grew significantly, with R&D spending up 90.2% and SG&A up 86.0%, though as a percentage of revenue these costs declined sharply.

• · Operating income margin improved to 33.3% of revenue in FY2026 from 8.5% in FY2025.
• · Total operating expenses as a percentage of revenue fell to 34.7% from 56.3%.
• · Other income, net decreased to 2.3% of revenue from 4.1%.
• · The company leases 317,449 square feet across six locations, with the largest footprint in the U.S. (143,945 sq ft) and Mainland China (99,088 sq ft).

15-06-2026

Northern Minerals & Exploration Ltd. (NMEX) reported its first-ever revenue of $22,901 for the nine months ended April 30, 2026, compared to zero in the prior-year period, driven by initial oil and gas production. However, the company's net loss widened to $232,258 from $184,859, and total liabilities surged to $645,542 from $385,613, while stockholders' deficit deepened to ($412,106) from ($223,348). The company also invested $42,139 in Bitcoin, now valued at $38,220, and relied heavily on related-party loans of $242,000 to fund operations.

• · Revenue of $22,901 for nine months ended April 30, 2026 came from initial oil and gas production, with cost of revenue of $19,225 resulting in a gross margin of $3,676.
• · Operating expenses for the nine months ended April 30, 2026 totaled $217,762, up from $175,627 in the prior year, driven by increases in officer compensation ($31,000 vs $20,400), director compensation ($17,400 vs $0), and professional fees ($77,448 vs $57,246).
• · Interest expense for the nine months ended April 30, 2026 was $14,253, up from $9,232, reflecting higher debt levels.
• · Unrealized loss of $3,919 on Bitcoin investment was recognized during the nine months ended April 30, 2026.
• · Net cash used in operating activities was $187,236 for the nine months ended April 30, 2026, compared to $133,907 in the prior year.
• · The company had no cash paid for taxes in either period.
• · Non-cash investing and financing activities included common stock issued for oil and gas rights ($267,200) and for debt settlement ($56,865) in the prior year, with none in the current period.
• · The standardized measure of discounted future net cash flows from oil and gas properties was $156,671 as of April 30, 2026.
• · Future cash inflows from oil and gas properties are estimated at $523,015, with future development costs of $10,875 and future LOE of $273,427.
• · The company's accumulated deficit grew to ($4,154,053) from ($3,921,795) as of July 31, 2025.
• · Weighted average shares outstanding increased to 110,668,419 for the nine months ended April 30, 2026 from 105,466,473 in the prior year.

15-06-2026

Vitro Biopharma, Inc. reported its quarterly results for the period ending April 30, 2026. For the first six months, total revenue grew modestly by 1.5% YoY to $975,712, partially offset by a 12.8% decline in Q3 revenue to $446,295. The company recorded a net loss available to common stockholders of $1.59M in Q3 (worsened from $1.48M) and a six-month net loss of $2.73M (improved from $4.31M). Cash dropped significantly from $604,183 to $122,577, while total liabilities remained high at $20.9M, resulting in a stockholders' deficit of $16.5M. Key growth product InfiniVive surged 700% YoY in Q3, but AlloRx Stem Cells sales to foreign clinics plummeted 72%.

• · The company had a stockholders' deficit of $16,533,041 as of April 30, 2026, compared to $16,333,667 as of October 31, 2025, indicating negative equity.
• · Total current liabilities surged to $16,625,515 from $5,679,141, driven by a new $6,596,624 2025 Series Senior Secured Convertible Notes and a $4,764,588 derivative/warrant liability.
• · Goodwill remained unchanged at $3,171,581, representing a significant portion of total assets.
• · Accounts receivable decreased to $62,244 from $80,526, while inventory increased slightly to $138,919.
• · Net cash used in operating activities increased 37.3% YoY to $1,536,429, signaling worsening cash burn from operations.
• · Loss on extinguishment of debt was $312,550 in Q3 2026, with no comparable amount in Q3 2025.
• · Derivative/warrant liability valuation swung dramatically: current portion went from $66,032 to $4,764,588, while long-term portion fell from $5,505,710 to $31,835, largely due to reclassification.
• · In the six-month period, the company issued 94,065 Series A-1 Preferred Shares (50,000 + 5,000 + 39,065 via conversion) for gross proceeds of $1,100,000.
• · Amortization/accretion of debt discount was $891,430 in the six months, up from $367,356, reflecting increased debt costs.
• · Common shares outstanding increased modestly from 4,460,535 to 4,517,651, mainly due to cashless exercise of stock options.

15-06-2026

Rise Gold Corp. reported a net loss of $614,802 for Q3 FY2026 (three months ended April 30, 2026), improving from a $756,034 loss in the same quarter last year. For the nine-month period, the net loss widened to $3,198,410 from $2,070,760 in the prior year, driven by a significant increase in professional fees and geological costs. The company strengthened its balance sheet through a $6.98M private placement, boosting cash to $7.96M from $2.78M at July 31, 2025, and eliminating all debt.

• · Total stockholders' equity increased to $8,817,468 at April 30, 2026 from $3,263,085 at July 31, 2025.
• · The company had no credit facility or loan payable outstanding at April 30, 2026, compared to $129,001 in credit facility at July 31, 2025.
• · Accounts payable and accrued liabilities decreased to $630,071 from $762,620 at July 31, 2025.
• · Payable to related parties decreased to $40,000 from $187,801 at July 31, 2025.
• · Mineral property interests remained unchanged at $197,499.
• · The note receivable increased to $1,213,778 from $1,188,701 due to $25,077 in interest income amortization.
• · Assets held for sale were reduced to $0 from $100,000 at July 31, 2025, with the deposit liability also eliminated.
• · Deferred financing asset was fully impaired ($67,610) during the nine-month period.
• · Other income for the nine months was $204,426, up from $7,717 in the prior period.
• · The company issued shares through private placement, stock option exercises, and warrant exercises during the nine-month period.

15-06-2026

Comtech Telecommunications reported a net loss of $3.5M for Q3 FY26 (three months ended April 30, 2026), compared to net income of $33.9M in the same quarter last year. Net sales declined 16.4% YoY to $106.0M, while gross profit fell 7.4% to $36.1M. However, operating loss widened to $3.1M from $1.5M, and the company's retained deficit grew to ($39.9M) from ($6.9M) at July 31, 2025. Cash flow from operations improved to $19.1M (nine months) versus ($19.7M) in the prior period.

• · Operating loss for Q3 FY26 was $3.1M, compared to $1.5M in Q3 FY25.
• · Selling, general and administrative expenses decreased to $29.3M (Q3 FY26) from $30.2M (Q3 FY25).
• · Research and development expenses increased to $5.2M (Q3 FY26) from $4.4M (Q3 FY25).
• · Interest expense decreased to $11.5M (Q3 FY26) from $12.9M (Q3 FY25).
• · Change in fair value of warrants and derivatives was a gain of $12.5M in Q3 FY26 vs. gain of $49.5M in Q3 FY25.
• · Net cash provided by operating activities for nine months FY26 was $19.1M, compared to net cash used of $19.7M in the prior period.
• · Capital expenditures (purchases of PP&E) for nine months FY26 were $13.1M, up from $6.5M in the prior period.
• · Total liabilities decreased to $430.2M at April 30, 2026 from $446.9M at July 31, 2025.
• · Convertible preferred stock redemption value increased to $218.2M (including accrued dividends) from $204.2M.
• · Basic and diluted net loss per common share for Q3 FY26 was ($0.47), compared to ($0.49) in Q3 FY25.

15-06-2026

HAMMER TECHNOLOGY HOLDINGS CORP. reported a net loss of $95,491 for Q3 FY26, a significant improvement from the $386,010 net loss in Q3 FY25. For the nine-month period, net loss improved to $397,246 from a prior period net income of $553,994, which had been boosted by a $1.66M gain on disposal of subsidiaries. The company still generates no revenue, has an accumulated deficit of $32.2M, and negative stockholders' equity of $1.06M.

15-06-2026

enGene Holdings Inc. reported a net loss of $30.2M for Q2 FY2026 (three months ended April 30, 2026), compared to a net loss of $25.8M in the same quarter last year, representing a 17.1% increase in net loss. For the six-month period, net loss widened to $60.0M from $50.4M in the prior year period. However, the company strengthened its balance sheet significantly through a public offering and warrant issuance, raising $126.3M in gross proceeds and $23.3M from pre-funded warrants, boosting total assets to $307.5M from $221.5M at October 31, 2025.

• · Operating expenses for Q2 FY2026 were $32.0M, up from $27.1M in Q2 FY2025, a 17.9% increase.
• · Interest income for Q2 FY2026 was $2.7M, slightly up from $2.5M in Q2 FY2025.
• · Loss on extinguishment of debt of $0.5M recorded in the six months ended April 30, 2026; none in prior period.
• · Net cash used in operating activities for six months ended April 30, 2026 was $59.4M, compared to $48.6M in the prior year period.
• · Net cash provided by financing activities was $141.7M for six months ended April 30, 2026, versus only $0.2M in the prior year period.
• · Weighted-average common shares outstanding (basic and diluted) increased to 69.7M for Q2 FY2026 from 51.0M in Q2 FY2025.
• · Accumulated deficit grew to $432.0M as of April 30, 2026 from $372.0M at October 31, 2025.
• · Total liabilities decreased slightly to $52.4M from $53.8M at October 31, 2025.
• · Share-based compensation expense for six months ended April 30, 2026 was $6.9M, up from $4.5M in the prior year period.
• · Proceeds from maturities of marketable securities were $117.0M for six months ended April 30, 2026, compared to $41.8M in the prior year period.

15-06-2026

Helio Corp reported a net loss of $1,645,957 for Q2 FY2026 (three months ended April 30, 2026), compared to a net loss of $1,015,033 in the same quarter last year, a 62% increase in losses. Total revenue declined 61% to $457,316 from $1,172,260 in Q2 FY2025, driven by sharp drops in service fees, engineering fees, and materials revenue. However, the company significantly improved its cash position to $464,720 from $7,305 at October 31, 2025, and reduced total liabilities from $5,366,754 to $3,384,603, primarily through debt conversions and equity issuances.

• · Service fees revenue dropped 58% to $352,428 in Q2 FY2026 from $835,656 in Q2 FY2025.
• · Engineering fees revenue fell 55% to $42,733 from $94,524.
• · Materials revenue declined 74% to $62,155 from $242,080.
• · Gross profit decreased 37% to $122,607 from $194,365.
• · General and administrative expenses decreased 44% to $418,952 from $742,264 in Q2, but increased 106% to $3,011,208 for H1 FY2026 from $1,464,917 in H1 FY2025.
• · Professional fees surged 490% to $260,014 in Q2 FY2026 from $44,081.
• · The company recorded a loss on debt extinguishment of $239,663 in Q2 and $883,543 for H1 FY2026.
• · Amortization of debt discount was $383,342 in Q2 and $444,575 for H1 FY2026.
• · Change in fair value of derivative liabilities resulted in a loss of $130,150 in Q2 and $318,942 for H1 FY2026.
• · Weighted average shares outstanding (basic and diluted) increased to 23,758,674 in Q2 FY2026 from 11,263,633 in Q2 FY2025.
• · Basic and diluted net loss per share improved to $(0.07) from $(0.09) in Q2, but worsened to $(0.26) from $(0.17) for H1.
• · Embedded derivative liabilities (Level 3) increased to $621,423 at April 30, 2026 from $39,543 at October 31, 2025.

15-06-2026

Pillarstone Capital REIT reported a net loss of $725,000 for Q1 2023, a sharp reversal from net income of $212,000 in Q1 2022. Total revenues declined 9.1% to $2.115 million, driven by lower rental revenue and transaction fees, while operating expenses surged 37.3% due to a spike in general and administrative costs. The company's net loss attributable to common shareholders widened to $254,000 from $17,000 year-over-year.

• · Net cash used in operating activities improved to -$88,000 from -$352,000 in Q1 2022.
• · Cash and cash equivalents decreased by $301,000 during Q1 2023 to $4.85 million.
• · Notes payable increased to $15.121 million from $14.642 million at year-end 2022.
• · Allowance for doubtful accounts rose to $728,000 at March 31, 2023 from $683,000 at December 31, 2022.
• · Real estate assets (net) declined slightly to $46.859 million from $47.226 million.
• · Accumulated deficit widened to $23.696 million from $23.442 million.

15-06-2026

Glidelogic Corp. (GDLG) reported zero revenue for Q1 FY2026 (three months ended April 30, 2026), compared to $77 in the same period last year, and a net loss of $27,212, widening from a net loss of $14,890 in Q1 FY2025. Total assets increased to $18,469 from $5,196 as of January 31, 2026, but the company remains deeply insolvent with a stockholders' deficit of $153,124 and total liabilities of $171,593. Cash from operations was negative $42,804, and the company relied on $42,880 in related-party note payable proceeds to fund operations.

• · General and administrative expenses increased 81.8% YoY from $14,967 to $27,212.
• · Depreciation expense remained flat at $105 for both Q1 FY2026 and Q1 FY2025.
• · Accounts payable decreased from $2,945 (Jan 31, 2026) to $550 (Apr 30, 2026), a decline of 81.3%.
• · Prepaid expenses surged from $2,635 to $15,937, an increase of 504.8%.
• · The company has no deferred tax assets due to a full valuation allowance against its net operating loss carryforward.
• · No interest or income taxes were paid in either period.
• · The company's equipment (net book value $2,388) and website have not had any additions or disposals in the current or prior fiscal year.

15-06-2026

Quantumsphere Acquisition Corp (QUMSR) filed its annual report for the year ended March 31, 2026, reporting a net income of $978,206 compared to a net loss of $16,018 in the prior period (from inception on July 23, 2024 through March 31, 2025). The company completed its initial public offering (IPO) during the year, raising $82.8 million in gross proceeds and placing $84.8 million in a trust account. However, the company continues to incur operating losses ($1.08 million in FY2026) and has an accumulated deficit of $3.23 million as of March 31, 2026.

• · The company's operating loss increased from $17,639 in the prior period to $1,076,186 in FY2026, reflecting higher general and administrative expenses post-IPO.
• · Total shareholders' equity swung from a positive $8,982 as of March 31, 2025 to a deficit of $3,231,507 as of March 31, 2026, primarily due to the remeasurement of carrying value to redemption value ($8,307,036).
• · The company had $84,846,125 in investments held in a Trust Account as of March 31, 2026, representing the IPO proceeds held for future acquisition.
• · Deferred underwriting fee payable was $3,312,000 as of March 31, 2026, compared to $40,000 in the prior period.
• · The company issued 228,650 private placement units for $2,286,500 during FY2026.
• · Net cash used in operating activities was $947,443 in FY2026, compared to $69,080 in the prior period.
• · The company's accumulated deficit grew from $16,018 to $3,231,820, largely due to the reclassification of negative additional paid-in capital.